Gerald P. Stankus

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

Robert N. Willette, Weike Bao, Sandhya S. Nerurkar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 295 citations

Life Sciences, Pharmacology, Physiology +17

Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species

Adawia A. Alousi, Gerald P. Stankus, James C. Stuart et al. · Journal of Cardiovascular Pharmacology · 1983 · 149 citations

Medicine, Cardiology, Pharmacology +15

Urotensin-II: a novel systemic hypertensive factor in the cat

Kristeen Maniscalco, Gerald P. Stankus, Alexandra Wibberley et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 42 citations

Medicine, Veterinary Physiology, Renal Pathophysiology +2

Differential effects of two fluorescent probes on macrophage migration as assessed by manual and automated methods

Elizabeth M. Denholm, Gerald P. Stankus · Cytometry · 1995 · 37 citations

Life Sciences, Cell Biology, Immunology +15

The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems

David J. Behm, Gerald P. Stankus, Christopher Doe et al. · British Journal of Pharmacology · 2006 · 36 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +12